Clinical performance of primary HPV screening cut-off for colposcopy referrals in HPV-vaccinated cohort: Observational study.


Journal

BJOG : an international journal of obstetrics and gynaecology
ISSN: 1471-0528
Titre abrégé: BJOG
Pays: England
ID NLM: 100935741

Informations de publication

Date de publication:
01 2023
Historique:
revised: 14 06 2022
received: 26 03 2022
accepted: 25 06 2022
pubmed: 3 9 2022
medline: 23 12 2022
entrez: 2 9 2022
Statut: ppublish

Résumé

To understand the effect of changing from cytology-based to primary HPV screening on the positive predictive value (PPV) of colposcopy referrals for cervical intraepithelial neoplasia (CIN) in a cohort offered HPV vaccination. Retrospective pre/post observational cohort study. Scotland. 2193 women referred to colposcopy between September 2019 and February 2020 from cytology-based screening and between September 2020 and February 2021 from primary high-risk HPV (hrHPV) screening. Calculating positive predictive values (PPVs) for two cohorts of women; one having liquid-based cytology screening and the other, the subsequent hrHPV cervical screening as a pre/post observational study. Positive predictive values of LBC and hrHPV cut-offs for colposcopy referral for CIN at colposcopy. Three papers fitted our criteria; these reported results only for cytology-based screening. The PPV was lower for women in HPV-vaccinated cohorts indicating a lower prevalence of disease. Vaccination under the age of 17 had the lowest PPV reported. Scottish colposcopy data concerning hrHPV and cytology showed a non-significant difference between PPV (17.5%, 95% CI 14.3-20.7, and 20.6, 95% CI 16.7-24.5, respectively) for referrals with a cut-off of low grade dyskaryosis (LGD); both met the standard set of 8-25%. The hrHPV PPV (66.7, 95% CI 56.8-76.6) was comparable to cytology (64.1, 95% CI 55.8-72.4) for referrals with a cut-off of high grade dyskaryosis (HGD) but neither met the standard set of 77-92%. Current literature only provides PPVs for LBC and, overall, the vaccinated cohort had lower PPVs. Only LG dyskaryosis met PHE criteria. The PPV for HPV-vaccinated women undergoing either LBC or HR-HPV screening were not statistically different. However, similar to papers in the current literature, HG dyskaryosis (HGD) PPVs of both techniques did not meet the PHE threshold of 76.6-91.6% outlined in the cervical standards data report.

Identifiants

pubmed: 36054732
doi: 10.1111/1471-0528.17284
pmc: PMC10087227
doi:

Types de publication

Observational Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

210-213

Subventions

Organisme : AFZ Giles scholarship

Informations de copyright

© 2022 The Authors. BJOG: An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd.

Références

BMJ. 2019 Apr 3;365:l1161
pubmed: 30944092
BJOG. 2016 Jan;123(1):24-38
pubmed: 26099164
Int J Cancer. 2019 Jun 15;144(12):2964-2971
pubmed: 30536935
J Clin Virol. 2021 Apr;137:104756
pubmed: 33662921
Br J Cancer. 2014 Oct 28;111(9):1824-30
pubmed: 25180766
BMC Womens Health. 2011 Jan 20;11:2
pubmed: 21251278
J Fam Plann Reprod Health Care. 2016 Jan;42(1):43-51
pubmed: 26376822
Br J Cancer. 2020 Jul;123(1):155-160
pubmed: 32362659
BJOG. 2022 Jul;129(8):1261-1267
pubmed: 34894043
Br J Cancer. 2016 Mar 1;114(5):582-9
pubmed: 26931370
BMC Med Res Methodol. 2012 Oct 31;12:166
pubmed: 23114025
BJOG. 2017 Aug;124(9):1394-1401
pubmed: 28102931
BJOG. 2017 Aug;124(9):1386-1393
pubmed: 28102928
BJOG. 2023 Jan;130(2):210-213
pubmed: 36054732
Eur J Cancer. 2015 May;51(8):950-68
pubmed: 25817010
Infect Agent Cancer. 2015 Nov 19;10:47
pubmed: 26594236
Lancet. 2014 Feb 8;383(9916):524-32
pubmed: 24192252

Auteurs

Marikka Beecroft (M)

Aberdeen Centre for Women's Health Research (ACWHR), University of Aberdeen, Aberdeen, UK.

Mahalakshmi Gurumurthy (M)

Aberdeen Centre for Women's Health Research (ACWHR), University of Aberdeen, Aberdeen, UK.

Margaret E Cruickshank (ME)

Aberdeen Centre for Women's Health Research (ACWHR), University of Aberdeen, Aberdeen, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH